• The New Money
  • Posts
  • America's Greenland Ambition, A New Zcash Miner Is Coming To The Nasdaq, And Anthropic's AI Drug Discovery Partnership

America's Greenland Ambition, A New Zcash Miner Is Coming To The Nasdaq, And Anthropic's AI Drug Discovery Partnership

The markets and trends that matter, made simple. Discover what’s next.

Greenland And America Are On The Verge Of A Historic Security Deal

President Donald Trump publicly stated that the United States has entered into a new agreement with Greenland and the Kingdom of Denmark to allow the United States to have permanent control over the security of Greenland. Critical Metals (NASDAQ: CRML) is advancing one of the single largest rare earth projects in the world in Greenland and recently began a new 10,000 metre drilling program. Greenland Energy (NASDAQ: GLND) owns an oil project located in the historic Jameson Land Basin in East Greenland which potentially contains up to 13B barrels of recoverable oil.

Zcash Miner Fortitude Is Coming To Wall Street

Zcash mining company Fortitude recently entered into a reverse merger with HeartSciences (NASDAQ: HSCS) to become a publicly traded company, and has now named Hut 8 (NASDAQ: HUT) leader Jaime Leverton as CEO. Fortitude mined 72,696 Zcash in the first half of this year, representing a current value of over $100 million and approximately 28% of all network production.

Novo Nordisk Partners With Anthropic On AI Drug Discovery

Novo Nordisk (NYSE: NVO) struck a new partnership with Anthropic to begin using their Claude family of artificial intelligence models for drug discovery and internal software development. Novo Nordisk publicly stated they will test Claude Science on highly specific research and development workflows as well as targeting complex problems previously identified by Novo Nordisk scientists.

The Success Of GLP-1s Could Cause A Boom In Medical Aesthetics Next

GLP-1 weight loss can strip fat faster than skin can adapt, leaving loose skin, hollowed cheeks and a loss of fullness across the face and body. Conexeu Sciences (NASDAQ: CNXU) is targeting that growing aesthetic need with CXU™, an injectable platform in preclinical development designed to support tissue regeneration and restore lost volume.

The Sprint

The Markets This Week

+46.7% | Cango Inc.

+42.8% | Elmet Group

+31.9% | Tempus AI

+31.9% | Securitize

+26.9% | Rumble

Top Trends This Week

+18.7% | a16z

+14.0% | DePIN

+13.5% | Dan Morehead

+9.7% | Meme Coins

Looking to connect? Reach out and get in touch.

New here? Join our community of 100,000+ individuals interested in uncovering the world’s most exciting early stage companies.

Disclaimer: The New Money provides background information on early stage companies from publicly available sources. The New Money provides no advice on dealing in securities, is not a financial adviser and does not pretend to be so. This message is meant for information and educational purposes only. The information contained in this email is not to be considered factual or complete. Anybody interested in obtaining financial and other information on companies mentioned is advised to get it direct from the companies, or from their own investment adviser. The New Money does not intend for this information to be used to inform an investment decision. The New Money has been compensated by some of the companies mentioned in this email for awareness campaigns, which affects our ability to be unbiased. The Principals of The New Money may buy or sell shares of the mentioned companies without further notice. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities. The New Money and its principals and agents are not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Always do your own research and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy or Sell securities. No representation is being made that any stock trade will or is likely to achieve profits. Comparisons made to other featured companies or past performance is not indicative of future results.